1.Motion Correction in PET/CT Images.
Sang Keun WOO ; Gi Jeong CHEON
Nuclear Medicine and Molecular Imaging 2008;42(2):172-180
PET/CT fused image with anatomical and functional information have improved medical diagnosis and interpretation. This fusion has resulted in more precise localization and characterization of sites of radio-tracer uptake. However, a motion during whole-body imaging has been recognized as a source of image quality degradation and reduced the quantitative accuracy of PET/CT study. The respiratory motion problem is more challenging in combined PET/CT imaging. In combined PET/CT, CT is used to localize tumors and to correct for attenuation in the PET images. An accurate spatial registration of PET and CT image sets is a prerequisite for accurate diagnosis and SUV measurement. Correcting for the spatial mismatch caused by motion represents a particular challenge for the requisite registration accuracy as a result of differences in PET/CT image. This paper provides a brief summary of the materials and methods involved in multiple investigations of the correction for respiratory motion in PET/CT imaging, with the goal of improving image quality and quantitative accuracy.
Positron-Emission Tomography and Computed Tomography
2.Combined PET/CT in Oncology.
Korean Journal of Nuclear Medicine 2002;36(1):80-86
No abstract available.
Positron-Emission Tomography and Computed Tomography*
3.Combined PET/CT in Oncology.
Korean Journal of Nuclear Medicine 2002;36(1):80-86
No abstract available.
Positron-Emission Tomography and Computed Tomography*
4.PERCIST in Perspective
Nuclear Medicine and Molecular Imaging 2018;52(1):1-4
Positron Emission tomography Response Criteria In Solid Tumors (PERCIST) version 1.0 was introduced in 2009 for objective assessment of tumor metabolic response using ¹⁸F-FDG PET/CT. Practical PERCIST: A Simplified Guide to PET Response Criteria in Solid Tumors 1.0 was published in 2016 to review and clarify some of the issues with the PERCIST. In this article, we reflect on the benefits and challenges of implementing PERCIST, and speculate on topics that could be discussed in PERCIST 1.1 in the future.
Positron-Emission Tomography
;
Positron-Emission Tomography and Computed Tomography
5.Radiation nephritis: (99m)Tc hydroxydiphosphonate bone scan, (99m)Tc dimercaptosuccinic acid renal scan, and ¹⁸F-FDG PET/CT findings.
Hye Lim PARK ; Ie Ryung YOO ; Yeon Sil KIM ; Jin Hyoung KANG ; Ji Eun LEE
The Korean Journal of Internal Medicine 2018;33(4):837-838
No abstract available.
Nephritis*
;
Positron-Emission Tomography and Computed Tomography*
;
Succimer*
6.Adjunctive role of dual time point imaging in evaluating bone lesions with increased 18F-PSMA-1007 uptake
Patrick Earl A. Fernando ; Jamilla Cecilia L. Gomez
The Philippine Journal of Nuclear Medicine 2023;18(2):14-17
Background:
Non-specific focal uptake in the skeleton is a diagnostic pitfall on 18F-PSMA-1007 PET/CT, but adjunctive
measures to aid interpretation of these lesions are currently lacking. We present two cases where dual time
point imaging provided additional information.
Case Presentation:
The first patient had a PI-RADS 3 lesion on MRI. No PSMA-avid abnormality was seen on PET, save for focal
uptake in the right pubis with no anatomic correlate. Additional imaging showed a decrease in lesion SUV, and
this was interpreted as benign. Another patient, diagnosed with prostate cancer, had multiple PSMA-avid pelvic
foci. Two suspiciously malignant bone lesions had increasing SUV trend after dual time point imaging despite
only faint sclerosis on CT. In contrast, one faint PSMA-avid lesion with no anatomic abnormality was read as
benign after a decrease in SUV. A decrease in lesion SUV may point to a benign etiology, while an increase
would heighten suspicion for malignancy. One possible molecular explanation is that a true
PSMA-overexpressing lesion would bind to the tracer for a longer period than a false positive.
Conclusion
Dual time point imaging provides additional information that may be useful in the interpretation of non-specificskeletal lesions with increased 18F-PSMA-1007 uptake.
PSMA-1007
;
Positron Emission Tomography Computed Tomography
7.Oral cancer diagnosed using PET/CT: A case report.
Young Hee KIM ; Byoung Eun YANG ; Young Min CHO ; Seong Gon KIM
Korean Journal of Oral and Maxillofacial Radiology 2006;36(2):111-116
PET/CT is a new imaging technology that combines high-quality Positron Emission Tomography (PET) and Computed Tomography (CT). This imaging provides simultaneous anatomical and metabolic information. Therefore PET/CT is useful diagnostic modality for early detection of malignant tumor, accurate staging, decision on therapeutic plan, monitoring response to therapy and rapid detection of recurrence. We report oral and maxillofacial cancers diagnosed by using PET/CT and the usefulness of PET/CT in the evaluation of postoperative recurrence.
Mouth Neoplasms*
;
Positron-Emission Tomography
;
Positron-Emission Tomography and Computed Tomography*
;
Recurrence
;
Tomography, X-Ray Computed
8.Study on PET/CT Service Life Based on Key Components.
Nan LI ; Wentao LU ; Weiqiang ZHANG ; Jinlin ZOU
Chinese Journal of Medical Instrumentation 2021;45(3):256-260
In this study, through the analysis of the composition of domestic large radioactive medical equipment PET/CT and the characteristics of each subsystem, combing the vulnerable spots, according to the standard requirements of PET/CT for 10 years in its service life, we research the PET/CT service life's effectiveness. Firstly, this study introduces the concept of service life, the relationship between service life and risk analysis, the pivotal system composition of PET/CT, the importance of reliability of each component, the traditional test method to verify its reliability is researched. This study suggests a test procedure and method to prove the reliability of various components of PET/CT equipment during the service life. This method is described in detail, and the specific test process in practical engineering application is discussed, which proves that it is beneficial to ensure the effectiveness of PET/CT during the service life.
Positron Emission Tomography Computed Tomography
;
Positron-Emission Tomography
;
Reproducibility of Results
;
Tomography, X-Ray Computed
9.Consideration on Animal Experiment in PET/CT.
Xiaofang GU ; Yaqing BAO ; Liping HE
Chinese Journal of Medical Instrumentation 2022;46(4):454-458
PET/CT imaging can reflect the physiological metabolic process in living body which is the model experiment incapable to simulate. Animal experiment may be considered for systematic validation of PET/CT products. The obtained research data can be used to evaluate the feasibility, effectiveness and safety of PET/CT products, and be submitted as supporting documents for research data or clinical evaluation data when doing product registration or alteration registration. In this study, the functions and advantages of animal experiments were expounded, and relevant research cases were given as well as the issues that should be paid attention to. It can be a reference for the validation and review of PET/CT products.
Animal Experimentation
;
Animals
;
Positron Emission Tomography Computed Tomography
;
Positron-Emission Tomography
;
Tomography, X-Ray Computed
10.Monte Carlo Simulation Codes for Nuclear Medicine Imaging.
Yong Hyun CHUNG ; Cheol Ha BEAK ; Seung Jae LEE
Nuclear Medicine and Molecular Imaging 2008;42(2):127-136
Monte Carlo simulation methods are especially useful in studying a variety of problems difficult to calculate by experimental or analytical approaches. Nowadays, they are extensively applied to simulate nuclear medicine instrumentations such as single photon emission computed tomography (SPECT) and positron emission tomography (PET) for assisting system design and optimizing imaging and processing protocols. The goal of this paper is to address the practical issues, a potential user of Monte Carlo simulations for nuclear medicine can encounter, to help them to choose a code. This review introduces the different types of Monte Carlo codes currently available for nuclear medicine, comments main features and properties for a code to be proper for a given purpose, and discusses current research trends in Monte Carlo codes.
Nuclear Medicine
;
Positron-Emission Tomography
;
Tomography, Emission-Computed, Single-Photon